Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress
Lifang Luo, Bing Dong, Jianning Zhang, Yumin Qiu, Xiaolin Liu, Zhe Zhou, Jiang He, Xiaoyu Zhang, Long Chen, Wenhao Xia, Wenhao Xia
Topics & Concepts
DapagliflozinAMPKProgenitor cellOxidative stressInflammationMedicineDiabetes mellitusEndocrinologyInternal medicineType 2 Diabetes MellitusStem cellBiologyProtein kinase ACell biologyKinaseAngiogenesis and VEGF in CancerRetinal Diseases and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases